Expert Practical Recommendations for Hepatocellular Carcinoma.
This review article outlines contemporary, practice-oriented guidance for managing hepatocellular carcinoma (HCC) across...
Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma.
- Post category:Digestive (CRC, Stomach) System
- Reading time:2 mins read
This study analyzed patient-reported outcomes (PROs) from NRG/RTOG 1010, a randomized trial adding trastuzumab to standa...
Poor clinical outcomes and immunoevasive contexture in gastric cancer patients bearing p16 high phenotype.
- Post category:Digestive (CRC, Stomach) System
- Reading time:2 mins read
Study question The investigators evaluated how different p16 (p16^INK4a) immunohistochemical staining patterns in gast...
Nonoperative Management of Hepatic Adenomas: A Review.
- Post category:Digestive (CRC, Stomach) System
- Reading time:2 mins read
This publication is a narrative review focused on current understanding and management of hepatic adenomas (HAs). Key p...
[Guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in China(2026 edition)].
- Post category:Digestive (CRC, Stomach) System
- Reading time:2 mins read
This publication presents the 2026 updated Chinese guidelines for the diagnosis and treatment of hepatocellular carcinom...
Providing holistic care for patients with metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions.
- Post category:Digestive (CRC, Stomach) System
- Reading time:2 mins read
This review article discusses metabolic dysfunction-associated steatotic liver disease (MASLD) as a highly prevalent con...